Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 115 is classified as a pseudogene in the human genome and is identified on chromosome 11 at position 11q22.1. Pseudogenes are non-functional sequences resembling known genes but typically do not produce functional proteins or RNAs. RN7SKP115 shares sequence similarity with the active RN7SK gene, which encodes the RNA component of the 7SK nuclear ribonucleoprotein complex—a regulatory RNA involved in transcriptional control in human cells. However, there is no evidence that RN7SKP115 itself participates in any biological process or serves as a therapeutic target. Standard gene databases do not link RN7SKP115 to any known function, disease, or pharmaceutical interaction. No information is available to indicate RN7SKP115 plays a role as a receptor, enzyme, transporter, transcription factor, or drug target. The lack of functional annotation confirms it is not considered a therapeutic target, and its inclusion as such would be incorrect.
no mechanisms of action; not a drug target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 115 (RN7SKP115).